Pricing Log in Create free account

Benitec Biopharma Limited (BNTC) vs X4 Pharmaceuticals, Inc. (XFOR)

Benitec Biopharma Limited and X4 Pharmaceuticals, Inc. are both Biotechnology companies. Benitec Biopharma Limited and X4 Pharmaceuticals, Inc. are of similar size ($304.4M and $301.5M). Benitec Biopharma Limited grew revenue faster over the last twelve months: −1.32% against −50.1%. Benitec Biopharma Limited has the higher net margin (0.00% vs −474.7%) and the higher return on invested capital (0.00% vs −178.2%). Across the 17 metrics below, Benitec Biopharma Limited leads on 11 and X4 Pharmaceuticals, Inc. on 6.

Valuation

Metric BNTC XFOR Biotechnology median
P/E n/m n/m 10.60
P/S 5,897.35 23.50 9.40
P/B 2.50 2.87 2.13
Price to free cash flow n/m 16.91 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 3,499.75 17.02 9.02
Earnings yield (10.32%) (21.26%) (32.88%)
Free cash flow yield (3.76%) 5.91% (23.13%)

Profitability

Metric BNTC XFOR Biotechnology median
Gross margin 0.00% 81.77% 68.51%
Operating margin 0.00% (473.95%) 0.00%
Net margin 0.00% (474.74%) 0.00%
Free cash flow margin 0.00% (478.16%) 0.00%
Return on equity (33.21%) (80.32%) (51.96%)
Return on assets (32.28%) (40.73%) (46.06%)
Return on invested capital 0.00% (178.23%) 0.00%

Growth

Metric BNTC XFOR Biotechnology median
Revenue growth (TTM) (1.32%) (50.08%) 6.76%
EPS growth (last fiscal year) 6.67% 67.23% 29.88%
Revenue growth, 5-year CAGR (54.02%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTC XFOR Biotechnology median
Debt to equity 0.00 0.55 0.00
Current ratio 34.00 13.22 4.97
Net debt to EBITDA 3.52 2.06 1.01

Dividend

Metric BNTC XFOR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BNTC XFOR Biotechnology median
Market cap 301.45m 304.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack